A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in in vitro fertilization (Lotus II): results from the Chinese mainland subpopulation

Dong-Zi Yang, Georg Griesinger, Wei Wang, Fei Gong, Xiaoyan Liang, Hanwang Zhang, Yingpu Sun, Elke Kahler, Claire Pexman-Fieth, Jan I Olofsson, Herman Tournaye, Zi-Jiang Chen

Klinik für Frauenheilkunde und Geburtshilfe

a Department of Obstetrics and Gynecology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University , Guangzhou , China.
c State Key Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University , Nanjing , China.
d Reproductive & Genetic Hospital of Citic-Xiangya , Changsha , China.
e Reproductive Medicine Research Center, Sixth Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China.
f Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , Hubei , China.
g Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University , Zhengzhou , China.
h Abbott Laboratories GmbH , Hannover , Germany.
i Abbott GmbH & Co. KG , Wiesbaden , Germany.
j Abbott Products Operations AG , Allschwil , Switzerland.
Karolinska Institutet
l Center for Reproductive Medicine, University Hospital of the Brussels Free University , Brussels , Belgium.
m Center for Reproductive Medicine, Shandong University , Jinan , China.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science